Prev Next

"Spedia-NMR gave us rapid and efficient access to the concentration profiles of feed components and metabolites to fine-tune our cell culture process." Bram Bout, CTO at Profibrix

  "Spinnovation collaborated with Merck Sharp & Dohme on the development of NMR assays for biologics."             

Merck Sharp & Dohme

  "The Spedia-NMR™ service brings new insights into our cell lines metabolism which enables us to further optimize its performance." Vivalis.              

Call Us: +31-24-240-3400

Email: info@spinnovation-biologics.com

Get A Quote

News

News
17th December 2014 - Spinnovation Analytical receives GMP certification for testing drug substances and drug products to support market release

NEWS RELEASE

 Spinnovation Analytical receives GMP certification for testing drug substances and drug products to support market release

 17 December 2014: Spinnovation Analytical BV, Oss, The Netherlands: Spinnovation has been granted a certification of Good Manufacturing Practices (GMP) compliance by the Dutch Health Care Inspectorate. This certifies that Spinnovation is qualified to test pharmaceutical drug substances and products for market release. GMP certification is recognition of Spinnovation's adherence to the highest quality management procedures and standards, and will support the company in delivering the QC testing services and analytical solutions for clients involved in the manufacturing and release of small molecule drugs and biologicals.

Read more...
 
19th September 2014 - Sinensis Life Sciences Acquires Spinnovation

NEWS RELEASE | September 19, 2014, Leiden, Oss, the Netherlands (in English)

Sinensis Life Sciences Acquires Spinnovation

Sinensis Life Sciences B.V., Leiden, the Netherlands (“Sinensis”), announces today that it has acquired Spinnovation Holding B.V., Oss, the Netherlands (“Spinnovation”), a contract research organisation specialised in the application of nuclear magnetic resonance (NMR) techniques in the pharmaceutical and biotechnological market. Financial terms of the transaction were not disclosed.

Read more...
 
5th February 2014 - New article by Spinnovation Biologics CEO Frederic Girard details NMR for QbD biologics development

NEWS RELEASE

New article by Spinnovation Biologics' CEO Frederic Girard details NMR for QbD biologics development

5 February 2014: Spinnovation Analytical BV, Oss, The Netherlands: Frederic Girard, CEO of Spinnovation Biologics, has authored a new article detailing the benefits of novel Spedia-NMR™ and NMR technology for Quality by Design (QbD) process development within biologics production. Entitled 'Fingerprinting Culture Media', the article was published in January 2014's edition of European Biopharmaceutical Review and is now available for download online at http://bit.ly/SPI0059.

Read more...
 
13th January 2014 - Spinnovation transfers its entire operation to Pivot Park to support the growth of its activities

NEWS RELEASE

Spinnovation transfers its entire operation to Pivot Park to support the growth of its activities

 13 January 2014: Spinnovation Analytical BV, Nijmegen, The Netherlands: Specialist analytical services provider Spinnovation Analytical BV has today announced the transfer of its entire operations to Pivot Park in Oss, the Netherlands. Since 2013, Spinnovation has collaborated with Pivot Park by supplying analytical services to life science companies based on the site. The new location has enabled Spinnovation to double the size of its facilities, to support the growth of its business.

Read more...
 
1st November 2013 - Spinnovation Biologics introduces new Elemental and Trace Metals Analysis for Cell Culture Media

NEWS RELEASE

Spinnovation Biologics introduces new Elemental and Trace Metals Analysis for Cell Culture Media

1st November 2013: Spinnovation Analytical BV, Nijmegen, The Netherlands: To offer a more complete analysis platform for cell culture, Spinnovation introduces new Elemental Analysis for cell culture media and raw materials.

Read more...
 
13 August 2013 - Spinnovation Biologics CEO Frederic Girard joins fellow industry experts for a QbD round table

NEWS RELEASE

Spinnovation Biologics CEO Frederic Girard joins fellow industry experts for a QbD round table

August 13th, 2013: Spinnovation, Nijmegen, The Netherlands: A new article detailing a round table discussion on quality by design (QbD) authored by leading industry experts including Spinnovation Biologics CEO Frederic Girard is now available online. Entitled 'QbD and PAT in Upstream and Downstream Processing', the article details the fundamental principles of QbD, how it is used to improve process control, and the impact technological advances have made on QbD biopharmaceutical upstream process optimization.

Read more...
 
11 March 2013 - Pivot Park and Spinnovation Analytical join forces

NEWS RELEASE

Pivot Park and Spinnovation Analytical join forces to provide analytical solutions at Pivot Park Life Sciences Community, Oss

11 March 2013: Spinnovation Analytical BV, Nijmegen, The Netherlands: Spinnovation Analytical B.V. and Pivot Park have entered into an agreement where Spinnovation will supply analytical services at the newly established life sciences park, while gaining access to Pivot Park’s advanced analytical platform.

Read more...
 
19 November 2012 - Fastest Spent Media Analysis Validated against ICH Guidelines

NEWS RELEASE

Fastest Spent Media Analysis Validated against ICH Guidelines

Spinnovation Biologics' Spedia-NMRTM Meets Stringent Pharma Guidelines

19 November 2012: Spinnovation, Nijmegen, The Netherlands: The increasingly popular cell culture analysis and optimization method, Spedia-NMR™ from Spinnovation Biologics, has now been validated internally in accordance to industry guidelines for analytical procedures issued by the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH).

Read more...
 
18 April 2012 - Spinnovation Biologics Predicts Biomanufacturing Success

NEWS RELEASE

Spinnovation Biologics Predicts Biomanufacturing Success

18 April 2012: Spinnovation Biologics, Nijmegen, The Netherlands: With expertise and know-how in high-end analysis for biologics, Spinnovation Biologics today announces the launch of a breakthrough solution – Spedia-Predict™ – for Bioprocess performance troubleshooting and performance prediction of bioproduction, at the annual Bioprocess International European meeting.

Read more...
 
16 April 2012 - Achieving BioManufacturing Success

TALK ANNOUNCEMENT

Achieving BioManufacturing Success

Are you tackling the issue of biomanufacturing consistency? Attempting to get to the root causes and find solutions for cell culture performance variability in large-scale commercial production? Are you confident about how your cell media will perform?

If you are currently involved in addressing these issues, you'll already recognise that current technologies for characterising complex cell culture media are lacking. Good Manufacturing Practice (GMP) and FDA Quality by Design (QbD) approaches demand close control, but traditional analytical methodology are costly, time consuming and require sample preparation ahead of measurement. Crucially, they also lack the ability to characterize chemically complex media.

Frederic Girard, Spinnovation-Analytical's CEO will be announcing a new service to enable biomanufacturing consistency, for chemically-defined and complex media, at this week's annual Bioprocess International™ European meeting. Catch him on Wednesday, 18th April, 2012 at the Clarion Congress Hotel, Prague.

Can't make it? This e-mail address is being protected from spambots. You need JavaScript enabled to view it for the presentation PDF, or better still, give us a call.

 
<< Start < Prev 1 2 Next > End >>

Page 1 of 2
 

Spinnovation Biologics is part of Sinensis Life Sciences

visit website x